BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 83 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,051,441 | $7,760,000 | 1.61% |
X-Square Capital, LLC | 102,832 | $759,000 | 0.57% |
CORRADO ADVISORS, LLC | 78,945 | $582,000 | 0.35% |
Endurant Capital Management LP | 71,801 | $530,000 | 0.23% |
Baker Brothers Advisors | 4,093,447 | $30,210,000 | 0.23% |
KNOTT DAVID M | 76,653 | $566,000 | 0.21% |
L & S Advisors Inc | 83,125 | $613,000 | 0.10% |
DAFNA Capital Management LLC | 30,000 | $221,000 | 0.10% |
FARALLON CAPITAL MANAGEMENT LLC | 2,000,000 | $14,760,000 | 0.09% |
HARVEY CAPITAL MANAGEMENT INC | 31,200 | $230,000 | 0.09% |